Statera Biopharma, Lay Sciences announce intent to enter strategic partnership
Statera Biopharma has announced its intent to enter into a non-binding term sheet with regard to a strategic partnership with Lay Sciences.
Stay updated with breaking news from Lay Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Statera Biopharma has announced its intent to enter into a non-binding term sheet with regard to a strategic partnership with Lay Sciences.
FORT COLLINS, Colo., May 13, 2022 -- Statera Biopharma , a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, announced today...
Global launch of ImmunIgY, the first pre-formed oral antibody that neutralizes SARS-CoV-2 and all its known variants